Clinical Trial Update: Clinical Trial to Investigate Efficacy of LAS41004 in Psoriasis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating LAS41004 for psoriasis has completed its study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• LAS41004

Snippet

Sponsor: Almirall, S.A. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED